老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagenic Therapeutics Inc

1.62
-0.0300-1.82%
盘后：1.58-0.0398-2.46%19:57 EST
成交量：56.44万
成交额：94.97万
市值：313.45万
市盈率：-0.12
高：1.65
开：1.61
低：1.46
收：1.65
52周最高：14.28
52周最低：1.46
股本：193.49万
流通股本：191.49万
量比：5.32
换手率：29.47%
股息：- -
股息率：- -
每股收益(TTM):-13.0507
每股收益(LYR):-15.7868
净资产收益率：-512.79%
总资产收益率：-189.60%
市净率：-35.49
市盈率(LYR):-0.10

数据加载中...

总览公司新闻资讯公告
2022/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/07

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/05

重要事件披露

8-K - Current report
2021/10/01

重要事件披露

8-K - Current report
2021/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/19

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/26

重要事件披露

8-K - Current report
2021/07/02

重要事件披露

8-K - Current report
2021/06/21

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

重要事件披露

8-K - Current report
2021/04/26

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/26

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/23

SEC问询函

CORRESP [Cover] - Correspondence
更多